Audience: adult
After a telemedicine visit for Post-Exposure Prophylaxis (PEP) evaluation, you will typically receive guidance on whether PEP treatment is recommended based on your exposure risk. PEP is a short-term medication regimen aimed at preventing HIV infection after possible exposure. Your healthcare provider may prescribe antiretroviral medications if PEP is appropriate, which usually need to be started within 72 hours of exposure. Follow-up testing and monitoring are important parts of care after the visit. You may be advised to schedule in-person appointments for lab tests or further evaluation. It is important to watch for any side effects from medications and report any concerning symptoms promptly. Telemedicine can help assess your risk and initiate treatment quickly but cannot replace some in-person tests or emergency care. If you experience severe symptoms or have urgent concerns, seek immediate medical attention. This guide explains what to expect after your telemedicine visit and how to take care of yourself safely.
After your telemedicine visit, your healthcare provider will review your exposure details to decide if PEP is needed. If recommended, you will receive a prescription for antiretroviral medications to start as soon as possible, ideally within 72 hours of exposure. Your provider will explain how to take the medications and discuss possible side effects. You may also receive instructions on scheduling follow-up lab tests to check for HIV and other infections.
Starting PEP medications quickly is critical to reduce the chance of HIV infection. The treatment usually lasts 28 days. During this time, you should take the medications exactly as prescribed. Follow-up visits, either in-person or via telemedicine, are important to monitor your health, manage side effects, and perform HIV testing at recommended intervals, often at 4 to 6 weeks and 3 months after exposure.
PEP medications can cause side effects such as nausea, fatigue, headache, or diarrhea. Most side effects are mild and improve over time. However, if you develop severe symptoms like difficulty breathing, rash, or intense abdominal pain, contact your healthcare provider immediately. Keep a symptom diary to share during follow-up visits.
Telemedicine is useful for initial evaluation and follow-up but cannot replace emergency care. Seek immediate in-person medical attention if you experience severe allergic reactions, high fever, chest pain, difficulty breathing, or signs of infection. Also, if you miss doses of your medication or are unsure about your treatment, contact a healthcare professional promptly.
Telemedicine allows quick access to healthcare providers who can assess your exposure risk and start PEP treatment without delay. It is convenient and reduces barriers to care. However, some tests like blood work and HIV testing require in-person visits. Your provider will guide you on when and where to get these done safely.
PEP should be started as soon as possible, ideally within 72 hours after a possible HIV exposure. The sooner you start, the more effective it is at preventing infection.
Many healthcare providers can evaluate your need for PEP through telemedicine and prescribe medications remotely. However, some tests will require in-person visits.
Try to take your medication as scheduled. If you miss a dose, take it as soon as you remember unless it is close to the next dose. Contact your healthcare provider for guidance.
Common side effects include nausea, fatigue, headache, and diarrhea. These are usually mild and temporary. Contact your provider if side effects are severe or persistent.
Follow-up HIV testing is typically recommended at 4 to 6 weeks and again at 3 months after exposure to confirm you remain HIV-negative.
This telemedicine guidance is for educational purposes only and is not a substitute for in-person medical care. If you have urgent symptoms or concerns, seek immediate medical attention.